CJC Open · 2019 · 56 citations · 22 references
MedicineCardiologyNuclear MedicineCardiovascular GeneticsClinical CardiologyNuclear CardiologyAortic DiseaseAortic StenosisAortic Valve DiseaseCardiac BiomarkersCardiovascular DiseaseGenetic RiskAortic Calcification ImagingAortic Valve Calcification ProgressionAtherosclerosis RiskFluoride Positron Emission TomographyOxidized PhospholipidsPositron Emission Tomography QuantificationSignal-to-background RatioValve Calcification Assessment
BACKGROUND: Lipoprotein(a) (Lp[a]) is the preferential lipoprotein carrier of oxidized phospholipids (OxPLs) and a well-established genetic risk factor for calcific aortic valve stenosis (CAVS). Whether Lp(a) predicts aortic valve microcalcification in individuals without CAVS is unknown. Our objective was to estimate the prevalence of elevated Lp(a) and OxPL levels in patients with CAVS and to determine if individuals with elevated Lp(a) but without CAVS have higher aortic valve microcalcification. METHODS: We recruited 214 patients with CAVS from Montreal and 174 patients with CAVS and 108 controls from Québec City, Canada. In a second group of individuals with high (≥75 nmol/L, n = 27) or low (<75 nmol/L, n = 28) Lp(a) levels, 18F-sodium fluoride positron emission tomography/computed tomography was performed to determine the difference in mean tissue-to-background ratio (TBR) of the aortic valve. RESULTS: = 0.02). CONCLUSIONS: Elevated Lp(a) and OxPL levels are associated with prevalent CAVS in patients studied in an echocardiography laboratory setting. In individuals with elevated Lp(a), evidence of aortic valve microcalcification by 18F-sodium fluoride positron emission tomography/computed tomography is present before the development of clinically manifested CAVS.
22
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Raphaël Rosenhek, Thomas Binder, Gerold Porenta et al. · New England Journal of Medicine · 2000 · 1.3K citations · Full text
Medicine, Cardiology, Surgery +12
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
Xuchu Que, Ming‐Yow Hung, Calvin Yeang et al. · Nature · 2018 · 518 citations